Clinical Trials Directory

Trials / Completed

CompletedNCT03938259

Effect of Opioids on Ventilation in Children With Obstructive Sleep Apnea

Status
Completed
Phase
Study type
Observational
Enrollment
52 (actual)
Sponsor
Baylor College of Medicine · Academic / Other
Sex
All
Age
2 Years – 8 Years
Healthy volunteers
Not accepted

Summary

The sole objective in this study is to evaluate if routine amounts of opioids given for tonsillectomy in children have greater amounts of respiratory depression in children with documented obstructive sleep apnea when compared with patients that do not have obstructive sleep apnea

Detailed description

Ventilatory suppression in children following opioid administration is of obvious concern, especially following routine surgical procedures (i.e. adenotonsillectomy). It is thought that patients with obstructive sleep apnea (OSA) have increased sensitivity to opioids, and especially in opioid naïve patients. Recent evidence in adults suggests that patients with moderate to severe OSA may not predispose patients to increased opioid sensitivity in the form of respiratory depression when compared with patients that do not have OSA. It is well known that OSA in children is significantly different from OSA in adults (e.g. gender predilection, central vs. peripheral causation). The manifestation and etiologies are very different in pediatric OSA making it a vastly different disease process.

Conditions

Interventions

TypeNameDescription
DRUGFentanylidentification of respiratory parameter changes following administration of fentanyl in children with and without OSA

Timeline

Start date
2019-07-01
Primary completion
2020-08-30
Completion
2020-08-30
First posted
2019-05-06
Last updated
2024-07-26
Results posted
2024-07-26

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03938259. Inclusion in this directory is not an endorsement.